A new murine monoclonal antibody for the diagnosis of erythroleukemia

L. A. Solberg, K. J. Oles, T. K. Kimlinger, Ayalew Tefferi, J. A. Katzmann, C. Y. Li

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The authors have developed a murine monoclonal antibody, RC-82.4, against an antigen expressed by a human erythroleukemia cell line OCI-MIR. The antibody reacts with an antigen expressed by proerythroblasts, normoblasts, and some reticulocytes but not expressed in erythrocytes, granulocytes, monocytes, megakaryocytes, plasma cells, or lymphocytes. The authors have established an immunocytochemical method for studying bone marrow smears with RC-82.4. By studying bone marrow smears from 11 patients with M-6 erythroleukemia and 104 patients with various other hematologic and nonhematologic malignancies, the authors have found that RC-82.4 has great sensitivity and specificity in recognizing erythroid differentiation in blasts. The authors have used RC-82.4 and antihemoglobin antibodies to identify erythroblasts in acute and secondary acquired cases of erythroleukemia that would have been unclassifiable by morphologic and all other conventional cytochemical and immunocytochemical criteria.

Original languageEnglish (US)
Pages (from-to)387-390
Number of pages4
JournalAmerican Journal of Clinical Pathology
Volume93
Issue number3
StatePublished - 1990

Fingerprint

Erythroblasts
Leukemia, Erythroblastic, Acute
Monoclonal Antibodies
Bone Marrow
Antigens
Megakaryocytes
Antibodies
Reticulocytes
Hematologic Neoplasms
Plasma Cells
Granulocytes
Monocytes
Erythrocytes
Lymphocytes
Sensitivity and Specificity
Cell Line

Keywords

  • acute undifferentiated leukemia
  • erythroleukemia
  • human erythroblastic cell line
  • immunocytochemistry
  • monoclonal antibodies

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Solberg, L. A., Oles, K. J., Kimlinger, T. K., Tefferi, A., Katzmann, J. A., & Li, C. Y. (1990). A new murine monoclonal antibody for the diagnosis of erythroleukemia. American Journal of Clinical Pathology, 93(3), 387-390.

A new murine monoclonal antibody for the diagnosis of erythroleukemia. / Solberg, L. A.; Oles, K. J.; Kimlinger, T. K.; Tefferi, Ayalew; Katzmann, J. A.; Li, C. Y.

In: American Journal of Clinical Pathology, Vol. 93, No. 3, 1990, p. 387-390.

Research output: Contribution to journalArticle

Solberg, LA, Oles, KJ, Kimlinger, TK, Tefferi, A, Katzmann, JA & Li, CY 1990, 'A new murine monoclonal antibody for the diagnosis of erythroleukemia', American Journal of Clinical Pathology, vol. 93, no. 3, pp. 387-390.
Solberg, L. A. ; Oles, K. J. ; Kimlinger, T. K. ; Tefferi, Ayalew ; Katzmann, J. A. ; Li, C. Y. / A new murine monoclonal antibody for the diagnosis of erythroleukemia. In: American Journal of Clinical Pathology. 1990 ; Vol. 93, No. 3. pp. 387-390.
@article{5e7b82ad0f3e4da0999d75fa28f6084a,
title = "A new murine monoclonal antibody for the diagnosis of erythroleukemia",
abstract = "The authors have developed a murine monoclonal antibody, RC-82.4, against an antigen expressed by a human erythroleukemia cell line OCI-MIR. The antibody reacts with an antigen expressed by proerythroblasts, normoblasts, and some reticulocytes but not expressed in erythrocytes, granulocytes, monocytes, megakaryocytes, plasma cells, or lymphocytes. The authors have established an immunocytochemical method for studying bone marrow smears with RC-82.4. By studying bone marrow smears from 11 patients with M-6 erythroleukemia and 104 patients with various other hematologic and nonhematologic malignancies, the authors have found that RC-82.4 has great sensitivity and specificity in recognizing erythroid differentiation in blasts. The authors have used RC-82.4 and antihemoglobin antibodies to identify erythroblasts in acute and secondary acquired cases of erythroleukemia that would have been unclassifiable by morphologic and all other conventional cytochemical and immunocytochemical criteria.",
keywords = "acute undifferentiated leukemia, erythroleukemia, human erythroblastic cell line, immunocytochemistry, monoclonal antibodies",
author = "Solberg, {L. A.} and Oles, {K. J.} and Kimlinger, {T. K.} and Ayalew Tefferi and Katzmann, {J. A.} and Li, {C. Y.}",
year = "1990",
language = "English (US)",
volume = "93",
pages = "387--390",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "3",

}

TY - JOUR

T1 - A new murine monoclonal antibody for the diagnosis of erythroleukemia

AU - Solberg, L. A.

AU - Oles, K. J.

AU - Kimlinger, T. K.

AU - Tefferi, Ayalew

AU - Katzmann, J. A.

AU - Li, C. Y.

PY - 1990

Y1 - 1990

N2 - The authors have developed a murine monoclonal antibody, RC-82.4, against an antigen expressed by a human erythroleukemia cell line OCI-MIR. The antibody reacts with an antigen expressed by proerythroblasts, normoblasts, and some reticulocytes but not expressed in erythrocytes, granulocytes, monocytes, megakaryocytes, plasma cells, or lymphocytes. The authors have established an immunocytochemical method for studying bone marrow smears with RC-82.4. By studying bone marrow smears from 11 patients with M-6 erythroleukemia and 104 patients with various other hematologic and nonhematologic malignancies, the authors have found that RC-82.4 has great sensitivity and specificity in recognizing erythroid differentiation in blasts. The authors have used RC-82.4 and antihemoglobin antibodies to identify erythroblasts in acute and secondary acquired cases of erythroleukemia that would have been unclassifiable by morphologic and all other conventional cytochemical and immunocytochemical criteria.

AB - The authors have developed a murine monoclonal antibody, RC-82.4, against an antigen expressed by a human erythroleukemia cell line OCI-MIR. The antibody reacts with an antigen expressed by proerythroblasts, normoblasts, and some reticulocytes but not expressed in erythrocytes, granulocytes, monocytes, megakaryocytes, plasma cells, or lymphocytes. The authors have established an immunocytochemical method for studying bone marrow smears with RC-82.4. By studying bone marrow smears from 11 patients with M-6 erythroleukemia and 104 patients with various other hematologic and nonhematologic malignancies, the authors have found that RC-82.4 has great sensitivity and specificity in recognizing erythroid differentiation in blasts. The authors have used RC-82.4 and antihemoglobin antibodies to identify erythroblasts in acute and secondary acquired cases of erythroleukemia that would have been unclassifiable by morphologic and all other conventional cytochemical and immunocytochemical criteria.

KW - acute undifferentiated leukemia

KW - erythroleukemia

KW - human erythroblastic cell line

KW - immunocytochemistry

KW - monoclonal antibodies

UR - http://www.scopus.com/inward/record.url?scp=0025363980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025363980&partnerID=8YFLogxK

M3 - Article

C2 - 1689945

AN - SCOPUS:0025363980

VL - 93

SP - 387

EP - 390

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 3

ER -